The FDA has updated its approval for 1-mg epinephrine nasal spray, removing the age limit to allow all patients weighing at least 33 lb to access the treatment. In a recent discussion with ...

A review of 6 drugs approved by the FDA in Q1 2026, with links to coverage from Contemporary Pediatrics. The first quarter of 2026 marked a period of profound advancement in pediatric health care, ...

The FDA has approved once-weekly somapacitan-beco for children aged 2.5 years and older with 3 separate growth indications. The FDA has approved somapacitan-beco (Sogroya; Novo Nordisk) 5 mg, 10 mg, ...

Clesrovimab demonstrated a similar safety profile to palivizumab across 2 RSV seasons, with no drug-related serious adverse events reported. Rates of RSV-associated, medically attended lower ...

Nontargeted testing identified 42 PFAS in cord blood, far exceeding the 8 compounds measured by traditional targeted methods, suggesting broader prenatal exposure. Cumulative exposure estimates ...

Early intervention services before aged 3 years were associated with greater odds of meeting third-grade math and English language arts standards. Academic benefits were most pronounced among children ...

Findings from the ELSA study show that population-based screening using a simple dried blood spot test is highly feasible and well accepted by families. In a Contemporary Pediatrics interview, Renuka ...

FDA approved caplacizumab for pediatric patients ≥12 years with acquired TTP, supported by retrospective data showing 80% remission. The FDA has approved Cablivi (caplacizumab-yhdp; Sanofi) for ...

FDA grants Breakthrough Device Designation to GeneDx genome and exome tests supporting diagnosis of life-threatening genetic disorders. The FDA has granted Breakthrough Device Designation to GeneDx’s ...

FDA approves Kygevvi, the first therapy for thymidine kinase 2 deficiency, a rare mitochondrial disease marked by muscle weakness and early death. The US Food and Drug Administration (FDA) has ...

The Committee voted against a proposed recommendation that "state and local jurisdictions should require a prescription for the administration of a COVID-19 vaccination.

Obstructive apneic events during sleep are rare in healthy children, with findings from studies showing very low rates of occurrence, often fewer than 1 event per hour, and duration of events ...